Evidence map›Paper›PMID 40041203›Full record

ArticleEnvironmental epidemiology (Philadelphia, Pa.)2025

Assessing the utility of healthcare claims data to determine potential health impacts of PFAS exposure with public drinking water.

Gonza Namulanda, Suzanne Condon, Terri Lynn Palmer, Elizabeth Ellis, Fuyuen Yip, Christopher M Reh, Patrick Breysse

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Environmental epidemiology (Philadelphia, Pa.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Gonza NamulandaDivision of Environmental Health Science and Practice, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA.ORCID https://orcid.org/0000-0003-4673-0327
Suzanne CondonNational Center for Environmental Health/Agency for Toxic Substances and Disease Registry, Centers for Disease Control and Prevention, Atlanta, GA.
Terri Lynn PalmerDelaware Health Information Network, Dover, DE.
Elizabeth EllisFreedman HealthCare, Burlington, MA.
Fuyuen YipDivision of Environmental Health Science and Practice, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA.
Christopher M RehNational Center for Environmental Health/Agency for Toxic Substances and Disease Registry, Centers for Disease Control and Prevention, Atlanta, GA.
Patrick BreysseNational Center for Environmental Health/Agency for Toxic Substances and Disease Registry, Centers for Disease Control and Prevention, Atlanta, GA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Healthcare claims data can support the timely surveillance of health outcomes from exposures to emerging and established environmental contaminants such as per- and polyfluoroalkyl substances (PFAS). PFAS are widely used in a variety of consumer products and industrial applications. They are detected in almost all Americans. PFAS exposure has been associated with several health outcomes including high cholesterol and thyroid disease. In 2014, PFAS were detected in five drinking water wells in New Castle City, New Castle County, Delaware. Perfluorooctane sulfonate and perfluorooctanoic acid were measured above the then Environmental Protection Agency's lifetime health advisory of 70 parts per trillion. This study uses healthcare claims data to show that healthcare plan members living in the ZIP code served by the five wells were at higher risk for type 2 diabetes, hypertension, hypertensive diseases, coronary artery disease, and hyperthyroidism based on new claims compared with healthcare plan members living elsewhere in the county. Healthcare claims data provided timely information on health outcomes not captured by traditional public health surveillance systems and at finer geographic levels.

Indexed as

cardiovascular diseaseendocrine disordershealthcare claimsmetabolic diseasesperfluoroalkylPFASpolyfluoroalkyl

Identifiers

PMID40041203
PMCPMC11878993

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.